Loredana Frasca

14PUBLICATIONS
17CO-AUTHORS
Molecular targetsClinical pharmacology and therapeuticsAutoimmunityHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 19, 2026
Tetrameric assembly disruption impairs CXCL4 chaperon ability for DNA and type I interferon immune amplification.

|Oct 16, 2025
The Phenomenon of Anti-Drug Antibodies in Psoriasis: Mechanisms, Clinical Impact, and Therapeutic Strategies.

Anna Mennella, Loredana Frasca

|Jul 29, 2025
Plasma CXCL4-DNA/RNA Complexes and Anti-CXCL4 Antibodies Modulation in an SSc Cohort under Iloprost Treatment.

Anna Mennella, Katia Stefanantoni, Raffaella Palazzo

|Mar 27, 2025
The Role of CXCL4 in Systemic Sclerosis: DAMP, Auto-Antigen and Biomarker.

Silvia Porreca, Anna Mennella, Loredana Frasca

|Mar 27, 2024
New, Old, and Shared Antibody Specificities in Autoimmune Diseases.

Loredana Frasca, Anna Mennella, Raffaella Palazzo

|Mar 11, 2023
Autoreactive T-Cells in Psoriasis: Are They Spoiled Tregs and Can Therapies Restore Their Functions?

Immacolata Pietraforte, Loredana Frasca

Pageof 3

Frequent Collaborators

7 joint publications

Roberto Lande

4 joint publications

Anna Mennella

4 joint publications

Anna Mennella

3 joint publications

Curdin Conrad